Associate Professor
Department of Neurosurgery, Duke University
Durham, NC, US
C. Rory Goodwin, MD, PhD is the Director for Spinal Oncology, Surgical Director for the Duke Center for Brain and Spine Metastasis and an Assistant Professor at the Duke University Medical Center. Dr. Goodwin attended the University of Florida where he majored in Neurobiological Sciences and Business Administration with minors in Chemistry and Economics. He obtained his M.D. and Ph.D. in Neuroscience from the Johns Hopkins University School of Medicine while also leading, founding, and participating in programs focused on future and current underrepresented minority students including serving as National President for the Student National Medical Association. He completed his Neurosurgery residency at the Johns Hopkins Hospital and has received research awards from the UNCF-Merck Science Initiative and the Burroughs Wellcome Fund, Robert Wood Johnson Foundation, and the NIH. Over the course of his training, he served as a Medical Officer for the Food and Drug Administration, Division of Orthopedic Devices, graduated from the Global Clinical Scholars Research Training Program at Harvard Medical School and also completed an in-folded Complex Spine Fellowship at The Johns Hopkins Hospital. Dr. Goodwin has a research interest in translational biomarkers and clinical outcomes for patients diagnosed with spinal tumors, and genomic and proteomic predictors in brain and spinal oncology.
Disclosure(s): Medtronic: Consultant (Ongoing); Stryker - K2M: Consultant (Terminated)
Integrating Molecular Markers and Genomics into Decision Making Frameworks: Feasible or Fantasy?
Wednesday, February 21, 2024
2:16 PM – 2:25 PM PST
Complications and How I Deal with Them
Wednesday, February 21, 2024
4:06 PM – 4:15 PM PST
Friday, February 23, 2024
8:21 AM – 8:24 AM PST
Regional Trends in Use of Intraoperative Neuromonitoring in Anterior Cervical Discectomy and Fusion
Friday, February 23, 2024
8:18 AM – 8:20 AM PST
Friday, February 23, 2024
8:40 AM – 8:42 AM PST
Saturday, February 24, 2024
7:10 AM – 7:12 AM PST
In Vivo Intraoperative Detection of Spine Tumor Margin Utilizing a Novel Laser Spectroscopy Device
Saturday, February 24, 2024
7:44 AM – 7:46 AM PST
Saturday, February 24, 2024
8:50 AM – 8:52 AM PST